{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:14:13Z","timestamp":1793654053737,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671616"],"award-info":[{"award-number":["81671616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871278"],"award-info":[{"award-number":["81871278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and technology Project of Jiangsu Province","award":["BE2018671"],"award-info":[{"award-number":["BE2018671"]}]},{"name":"Research Center of Gerontology and Longevity, Affiliated Hospital of Nantong University","award":["HS2018004"],"award-info":[{"award-number":["HS2018004"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX19-2071"],"award-info":[{"award-number":["KYCX19-2071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04753-5","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T06:08:55Z","timestamp":1569996535000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"39","author":[{"given":"Rui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4975-6426","authenticated-orcid":false,"given":"Chen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"issue":"2","key":"4753_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/annrheumdis-2017-212619","volume":"78","author":"S Nayar","year":"2019","unstructured":"Nayar S, Campos J, Smith CG, Iannizzotto V, Gardner DH, Colafrancesco S, Pipi E, Kollert F, Hunter KJ, Brewer C, Buckley CD, Bowman SJ, Priori R, Valesini G, Juarez M, Fahy WA, Fisher BA, Payne A, Allen RA, Barone F (2019) Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjogren\u2019s syndrome. Ann Rheum Dis 78(2):249\u2013260","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4753_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/ijerph16050771","volume":"16","author":"Chien-Yu Lin","year":"2019","unstructured":"Lin CY, Tseng CF, Liu JM et al (2019) Association between periodontal disease and subsequent Sjogren\u2019s syndrome: a nationwide population-based cohort study. Int J Environ Res Public Health 16(5)","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"10","key":"4753_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","volume":"17","author":"K Psianou","year":"2018","unstructured":"Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki A (2018) Clinical and immunological parameters of Sjogren\u2019s syndrome. Autoimmun Rev 17(10):1053\u20131064","journal-title":"Autoimmun Rev"},{"key":"4753_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2147\/PPA.S163417","volume":"12","author":"Y Cui","year":"2018","unstructured":"Cui Y, Li L, Xia L, Zhao Q, Chen S, Fu T, Ji J, Gu Z (2018) The impact of disease activity and psychological status on quality of life for Chinese patients with primary Sjogren\u2019s syndrome. Patient Prefer Adherence 12:1513\u20131519","journal-title":"Patient Prefer Adherence"},{"issue":"24","key":"4753_CR5","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1055\/a-0547-1025","volume":"143","author":"T Witte","year":"2018","unstructured":"Witte T (2018) Sjogren\u2019s syndrome: early diagnosis and effective treatment[J]. Dtsch Med Wochenschr 143(24):1778\u20131782","journal-title":"Dtsch Med Wochenschr"},{"key":"4753_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3389\/fimmu.2018.01106","volume":"9","author":"C Tsigalou","year":"2018","unstructured":"Tsigalou C, Stavropoulou E, Bezirtzoglou E (2018) Current insights in microbiome shifts in Sjogren\u2019s syndrome and possible therapeutic interventions. Front Immunol 9:1106","journal-title":"Front Immunol"},{"key":"4753_CR7","doi-asserted-by":"crossref","unstructured":"Price EJ, Baer AN 2019 How to treat Sjogren\u2019s syndrome[J]. Rheumatology (Oxford)","DOI":"10.1093\/rheumatology\/key363"},{"key":"4753_CR8","doi-asserted-by":"publisher","first-page":"14054","DOI":"10.1038\/npjpcrm.2014.54","volume":"24","author":"JD Zibrak","year":"2014","unstructured":"Zibrak JD, Price D (2014) Interstitial lung disease: raising the index of suspicion in primary care. NPJ Prim Care Respir Med 24:14054","journal-title":"NPJ Prim Care Respir Med"},{"issue":"11","key":"4753_CR9","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, Lu Y, Zheng Y (2018) A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren\u2019s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 37(11):2981\u20132988","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4753_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","volume":"16","author":"F Roca","year":"2017","unstructured":"Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, L\u00e9vesque H, Marie I (2017) Interstitial lung disease in primary Sjogren\u2019s syndrome. Autoimmun Rev 16(1):48\u201354","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4753_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s10067-017-3601-1","volume":"36","author":"A Manfredi","year":"2017","unstructured":"Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, Luppi F, Ferri C (2017) Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement. Clin Rheumatol 36(6):1261\u20131268","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4753_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/SPC.0000000000000285","volume":"11","author":"S Bajwah","year":"2017","unstructured":"Bajwah S, Yorke J (2017) Palliative care and interstitial lung disease. Curr Opin Support Palliat Care 11(3):141\u2013146","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"4753_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000077416","volume":"71","author":"A Chetta","year":"2004","unstructured":"Chetta A, Marangio E, Olivieri D (2004) Pulmonary function testing in interstitial lung diseases. Respiration 71(3):209\u2013213","journal-title":"Respiration"},{"issue":"3.4","key":"4753_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2152\/jmi.65.251","volume":"65","author":"T Kishaba","year":"2018","unstructured":"Kishaba T, Mcgill R, Nei Y et al (2018) Clinical characteristics of dermatomyosits\/polymyositis associated interstitial lung disease according to the autoantibody. J Med Invest 65(3.4):251\u2013257","journal-title":"J Med Invest"},{"issue":"150","key":"4753_CR15","doi-asserted-by":"publisher","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","volume":"27","author":"Vincent Cottin","year":"2018","unstructured":"Cottin V, Hirani NA, Hotchkin DL et al (2018) Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev 27(150)","journal-title":"European Respiratory Review"},{"issue":"151","key":"4753_CR16","doi-asserted-by":"publisher","first-page":"180100","DOI":"10.1183\/16000617.0100-2018","volume":"28","author":"Vincent Cottin","year":"2019","unstructured":"Cottin V, Wollin L, Fischer A et al (2019) Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev 28:\u2013151","journal-title":"European Respiratory Review"},{"issue":"3","key":"4753_CR17","first-page":"94","volume":"36 Suppl 112","author":"CF Kampolis","year":"2018","unstructured":"Kampolis CF, Fragkioudaki S, Mavragani CP et al (2018) Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 36 Suppl 112(3):94\u2013101","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4753_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017) the International Sj\u00f6gren\u2019s Syndrome Criteria Working Group 2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35\u201345","journal-title":"Arthritis Rheumatol"},{"key":"4753_CR19","doi-asserted-by":"crossref","unstructured":"Li L, Gao S, Fu Q, Liu R, Zhang Y, Dong X, Li Y, Li M, Zheng Y (2019) A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis. Clin Rheumatol","DOI":"10.1007\/s10067-019-04673-4"},{"key":"4753_CR20","unstructured":"Nocturne G 2019 [Sjogren\u2019s syndrome update: clinical and therapeutic aspects][J]. Rev Med Interne"},{"issue":"6","key":"4753_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00296-019-04285-w","volume":"39","author":"J Rosas","year":"2019","unstructured":"Rosas J, Sanchez-Piedra C, Fernandez-Castro M et al (2019) ESSDAI activity index of the SJOGRENSER cohort: analysis and comparison with other European cohorts. Rheumatol Int 39(6):991\u2013999","journal-title":"Rheumatol Int"},{"issue":"11","key":"4753_CR22","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1007\/s10067-018-4233-9","volume":"37","author":"Z Li","year":"2018","unstructured":"Li Z, Fu T, Li L, Cui Y, Dong C, Li J, Gu Z (2018) Prevalence, severity, and predictors of dry eye and dry mouth in Chinese patients with primary Sjogren syndrome. Clin Rheumatol 37(11):2971\u20132979","journal-title":"Clin Rheumatol"},{"issue":"10","key":"4753_CR23","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11136-013-0420-y","volume":"22","author":"SL He","year":"2013","unstructured":"He SL, Wang JH, Li M (2013) Validation of the Chinese version of the summated xerostomia inventory (SXI). Qual Life Res 22(10):2843\u20132847","journal-title":"Qual Life Res"},{"key":"4753_CR24","unstructured":"Bollmeier SG, Seaton TL, Prosser TR et al (2003) Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting. J Am Pharm Assoc 2019"},{"issue":"1","key":"4753_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12888-018-1715-x","volume":"18","author":"Y Cui","year":"2018","unstructured":"Cui Y, Xia L, Li L et al (2018) Anxiety and depression in primary Sjogren\u2019s syndrome: a cross-sectional study. BMC Psychiatry 18(1):131","journal-title":"BMC Psychiatry"},{"key":"4753_CR26","doi-asserted-by":"crossref","unstructured":"Miyamoto ST, Valim V, Fisher BA (2019) Health-related quality of life and costs in Sjogren\u2019s syndrome. Rheumatology (Oxford)","DOI":"10.1093\/rheumatology\/key370"},{"issue":"3","key":"4753_CR27","first-page":"373","volume":"34","author":"R Priori","year":"2016","unstructured":"Priori R, Minniti A, Antonazzo B et al (2016) Sleep quality in patients with primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 34(3):373\u2013379","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4753_CR28","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar3487","volume":"13","author":"K Haldorsen","year":"2011","unstructured":"Haldorsen K, Bjelland I, Bolstad AI et al (2011) A five-year prospective study of fatigue in primary Sjogren\u2019s syndrome. Arthritis Res Ther 13(5):R167","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"4753_CR29","first-page":"1077","volume":"34","author":"MH Chen","year":"2016","unstructured":"Chen MH, Chen CK, Chou HP et al (2016) Rituximab therapy in primary Sjogren\u2019s syndrome with interstitial lung disease: a retrospective cohort study. Clin Exp Rheumatol 34(6):1077\u20131084","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4753_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aalokken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data. Rheumatology (Oxford) 52(1):173\u2013179","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4753_CR31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hou Z, Qiu M, Ye Q (2018) Risk factors for primary Sjogren syndrome-associated interstitial lung disease. J Thorac Dis 10(4):2108\u20132117","journal-title":"J Thorac Dis"},{"key":"4753_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.rmed.2018.02.023","volume":"137","author":"T Kakugawa","year":"2018","unstructured":"Kakugawa T, Sakamoto N, Ishimoto H, Shimizu T, Nakamura H, Nawata A, Ito C, Sato S, Hanaka T, Oda K, Kido T, Miyamura T, Nakashima S, Aoki T, Nakamichi S, Obase Y, Saito K, Yatera K, Ishimatsu Y, Nakayama T, Korogi Y, Kawakami A, Tanaka Y, Mukae H (2018) Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjogren\u2019s syndrome. Respir Med 137:95\u2013102","journal-title":"Respir Med"},{"issue":"24","key":"4753_CR33","doi-asserted-by":"publisher","first-page":"e11003","DOI":"10.1097\/MD.0000000000011003","volume":"97","author":"H Gao","year":"2018","unstructured":"Gao H, Zhang XW, He J, Zhang J, An Y, Sun Y, Jia RL, Li SG, Zhang LJ, Li ZG (2018) Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjogren syndrome patients: a case-control study. Medicine (Baltimore) 97(24):e11003","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"4753_CR34","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, Ozbudak O, Terzioglu E (2010) Lung involvement in patients with primary Sjogren\u2019s syndrome: what are the predictors? Rheumatol Int 30(10):1317\u20131324","journal-title":"Rheumatol Int"},{"issue":"2","key":"4753_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1601-0825.2012.01932.x","volume":"19","author":"ID O\u2019neill","year":"2013","unstructured":"O\u2019neill ID, Scully C (2013) Biologics in oral medicine: Sjogren syndrome. Oral Dis 19(2):121\u2013127","journal-title":"Oral Dis"},{"issue":"3","key":"4753_CR36","doi-asserted-by":"publisher","first-page":"1900161","DOI":"10.1183\/13993003.00161-2019","volume":"54","author":"Lutz Wollin","year":"2019","unstructured":"Wollin L, Distler JHW, Redente EF, Riches DWH, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M (2019) Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J:1900161","journal-title":"European Respiratory Journal"},{"key":"4753_CR37","doi-asserted-by":"publisher","first-page":"272303","DOI":"10.1155\/2012\/272303","volume":"2012","author":"W Hartung","year":"2012","unstructured":"Hartung W, Maier J, Pfeifer M et al (2012) Effective treatment of rheumatoid arthritis-associated interstitial lung disease by B-cell targeted therapy with rituximab. Case Reports Immunol 2012:272303","journal-title":"Case Reports Immunol"},{"key":"4753_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.04.002","volume":"127","author":"JG Natalini","year":"2017","unstructured":"Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS (2017) Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med 127:1\u20136","journal-title":"Respir Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04753-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T23:30:38Z","timestamp":1601508638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04753-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4753"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04753-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"22 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Affiliated Hospital of Nantong University approved this study (ethics approval number: 2017-K003).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All participants obtained informed consent in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}